FindMyKOL

Srividya Kidambi, MD

Basic profile

Medical College of Wisconsin

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionMilwaukee, WI · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLFindMyKOL type: NationalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Srividya Kidambi is an Endocrinology/Metabolic physician affiliated with Medical College of Wisconsin. OpenAlex indexes 63 publications with 1,577 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
63publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

1,577citations

Citations across these publications.

22h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Chiesi
    Program year20241 paymentResearch
    $63
  • Novo Nordisk Inc
    Program year20241 payment
    $32
  • Regeneron
    Program year20231 paymentResearch
    $4,858
All 6 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    71.4%
    GLP-1 receptor agonist29%
    Ozempic55%Mounjaro27%Trulicity18%
    Part D≥41 patients
    Biguanide (metformin)25.3%
    Metformin Hcl Er90%Metformin Hcl10%
    Part D<11 patients

    + 3 more classes in this area

  • Hormonal (systemic)

    12.8%
    l-Thyroxine9.4%
    Levothyroxine Sodium100%
    Part D≥28 patients
    Thyroid Hormone Synthesis Inhibitor2.2%
    Methimazole100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    12.1%
    Statin5.9%
    Atorvastatin Calcium52%Rosuvastatin Calcium48%
    Part D<11 patients
    ACE inhibitor3.1%
    Lisinopril-Hydrochlorothiazide54%Lisinopril46%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”